Search

Your search keyword '"Wassmer, Evangeline"' showing total 507 results

Search Constraints

Start Over You searched for: Author "Wassmer, Evangeline" Remove constraint Author: "Wassmer, Evangeline"
507 results on '"Wassmer, Evangeline"'

Search Results

1. The diagnostic workup of children with the radiologically isolated syndrome differs by age and by sex

2. Long term outcome in non-multiple sclerosis paediatric acquired demyelinating syndromes

4. Genome sequencing and comprehensive rare-variant analysis of 465 families with neurodevelopmental disorders

5. Performance of the 2023 Adult Criteria for the Radiologically Isolated Syndrome in Children and Comparison to the 2009 Criteria (P4-6.007)

7. A framework for measurement and harmonization of pediatric multiple sclerosis etiologic research studies: The Pediatric MS Tool-Kit

8. Clinical trials of disease-modifying agents in pediatric MS: Opportunities, challenges, and recommendations from the IPMSSG

10. Safety and efficacy of teriflunomide in paediatric multiple sclerosis (TERIKIDS): a multicentre, double-blind, phase 3, randomised, placebo-controlled trial

11. Repurposing Clinical MRI Archives for Multiple Sclerosis Research with a Flexible, Single-Modality Approach: New Insights from Old Scans

14. E.U. paediatric MOG consortium consensus: Part 3 – Biomarkers of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders

15. E.U. paediatric MOG consortium consensus: Part 5 – Treatment of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders

16. E.U. paediatric MOG consortium consensus: Part 4 – Outcome of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders

17. E.U. paediatric MOG consortium consensus: Part 1 – Classification of clinical phenotypes of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders

18. E.U. paediatric MOG consortium consensus: Part 2 – Neuroimaging features of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders

19. Evolution of brain MRI lesions in paediatric myelinoligodendrocyte glycoprotein antibody- associated disease (MOGAD) and its relevance to disease course.

20. Evolution of brain MRI lesions in paediatric myelin-oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and its relevance to disease course

21. Neuroinflammatory Disease as an Isolated Manifestation of Hemophagocytic Lymphohistiocytosis

22. Gross Motor Function in Pediatric Onset TUBB4A-Related Leukodystrophy: GMFM-88 Performance and Validation of GMFC-MLD in TUBB4A

23. Do Early Relapses Predict the Risk of Long‐Term Relapsing Disease in an Adult and Paediatric Cohort with MOGAD?

24. International Pediatric MS Study Group Clinical Trials Summit

25. Clinical spectrum of POLR3-related leukodystrophy caused by biallelic POLR1C pathogenic variants

26. Real-World Effectiveness of Ocrelizumab in a Multi-Centre Pediatric-Onset Multiple Sclerosis (POMS) Cohort in the United Kingdom (S31.007)

27. Dynamic MRI Lesion Evolution in Pediatric Myelin-Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) (S27.006)

28. Evolution of brain MRI lesions in paediatric myelin-oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and its relevance to disease course

31. Efficacy and safety of cyclic pyranopterin monophosphate substitution in severe molybdenum cofactor deficiency type A: a prospective cohort study

32. VAMP2Gene-Related Neurodevelopmental Disorder: A Differential Diagnosis for Rett/Angelman-Type Spectrum of Disorders

34. Radiologically isolated syndrome in children: Clinical and radiologic outcomes

38. Progressive deafness–dystonia due to SERAC1 mutations: A study of 67 cases

39. Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension

40. Biallelic variants in ZNF142 lead to a syndromic neurodevelopmental disorder

43. Clinical features, investigations, and outcomes of pediatric limbic encephalitis:A multicenter study

44. Thiamine deficiency in childhood with attention to genetic causes: Survival and outcome predictors

45. Factors Associated With Relapse and Treatment of Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease in the United Kingdom

46. Clinical features, investigations, and outcomes of pediatric limbic encephalitis: A multicenter study

47. Pathogenic antibodies to AQP4:Neuromyelitis optica spectrum disorder (NMOSD)

48. Clinical and molecular characterisation of hereditary dopamine transporter deficiency syndrome: an observational cohort and experimental study

49. Safety and efficacy of teriflunomide in paediatric multiple sclerosis (TERIKIDS): a multicentre, double-blind, phase 3, randomised, placebo-controlled trial

Catalog

Books, media, physical & digital resources